An international panel of cancer genetic counselors with research and advocacy interests in LGBTQ+ affirming care, NHS Bristol’s Josephine Giblin, Dana-Farber Cancer Institute’s Diane Koeller, and Boston University School of Medicine’s Kimberly Zayhowski, discuss:
- Risk considerations for trans and gender diverse cancer genetic counseling patients
- Creating safe and inclusive environments in cancer genetic counseling
- Protecting patients during times of unprecedented legislation
- Resources and methods to support trans and gender diverse patients
Hosted by DNA Today's Kira Dineen.
Resources and further reading: